Stay updated on Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision marker was updated from v3.6.2 to v3.6.3, signaling a new version of the page.
    Difference
    0.0%
    Check dated 2026-07-03T22:41:44.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing Revision: v3.6.0. This indicates a small platform update to the page rendering.
    Difference
    0.0%
    Check dated 2026-06-27T00:16:41.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    New and updated study locations were added (e.g., Taichung Veterans General Hospital in Taichung, Taiwan; Nanfang Hospital, Southern Medical University; Guangzhou, Guangdong, China 510515), and the total number of locations changed from 88 to 90. The page now includes additional navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates to the Intervention/Treatment header.
    Difference
    0.5%
    Check dated 2026-06-12T15:54:10.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry labeled Revision: v3.5.5 with dates 2026-06-03 and 2026-06-02 was added to the page. The previous revision entry Revision: v3.5.4 with dates 2026-05-28 and 2026-05-27 appears to have been removed.
    Difference
    0.1%
    Check dated 2026-06-05T11:19:23.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Added Nanjing Drum Tower Hospital in Nanjing, China and Johns Hopkins Myositis Center in Baltimore, MD as new study sites, increasing the total number of locations to 88.
    Difference
    0.5%
    Check dated 2026-05-29T08:16:28.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the page, indicating a new version of the document. This appears to be an administrative update with no visible changes to the study details or data presented.
    Difference
    0.0%
    Check dated 2026-05-15T06:01:12.000Z thumbnail image

Stay in the know with updates to Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.